Generation Bio to Present at 39th Annual J.P. Morgan Healthcare Conference
January 05, 2021 06:30 ET
|
Generation Bio Co.
CAMBRIDGE, Mass., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), an innovative genetic medicines company creating a new class of non-viral gene therapy, announced today that...
Generation Bio Announces Two Non-Viral Gene Therapy Milestone Achievements: Target Levels of Factor VIII Expression in Hemophilia A Mice and Translation of Expression from Mice to Non-Human Primates
January 04, 2021 06:30 ET
|
Generation Bio Co.
Data confirm delivery of closed-ended DNA to the liver via novel, cell-targeted lipid nanoparticles Well tolerated at all dose levels in mice and non-human primates Company on track to select...
Generation Bio Reports Third Quarter 2020 Business Updates and Financial Results
November 10, 2020 06:30 ET
|
Generation Bio Co.
CAMBRIDGE, Mass., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO) is an innovative genetic medicines company creating a new class of non-viral gene therapy. Today the company...
Generation Bio to Present at 2020 Virtual Cell & Gene Meeting on the Mesa
October 05, 2020 06:30 ET
|
Generation Bio Co.
CAMBRIDGE, Mass., Oct. 05, 2020 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), an innovative genetic medicines company creating a new class of non-viral gene therapy, announced today that...
Generation Bio to Present at the Jefferies 2020 Virtual Gene Therapy/Editing Summit
September 24, 2020 06:30 ET
|
Generation Bio Co.
CAMBRIDGE, Mass., Sept. 24, 2020 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), an innovative genetic medicines company creating a new class of non-viral gene therapy, announced today that...
Generation Bio Reports Business Updates and Second Quarter 2020 Financial Results
August 11, 2020 06:30 ET
|
Generation Bio Co.
CAMBRIDGE, Mass., Aug. 11, 2020 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), an innovative genetic medicines company creating a new class of non-viral gene therapy, today reported recent...
Generation Bio to Present at 2020 Wedbush PacGrow Healthcare Virtual Conference
August 05, 2020 06:30 ET
|
Generation Bio Co.
CAMBRIDGE, Mass., Aug. 05, 2020 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), an innovative genetic medicines company creating a new class of non-viral gene therapy, today announced that...
Generation Bio Appoints Matthew Norkunas, M.D., MBA as Chief Financial Officer
July 22, 2020 07:00 ET
|
Generation Bio Co.
CAMBRIDGE, Mass., July 22, 2020 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), an innovative genetic medicines company creating a new class of non-viral gene therapy, today announced that...
Generation Bio Announces Closing of Initial Public Offering
June 16, 2020 16:02 ET
|
Generation Bio Co.
CAMBRIDGE, Mass., June 16, 2020 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), an innovative genetic medicines company creating a new class of gene therapy, today announced the closing of...
Generation Bio Announces Pricing of Initial Public Offering
June 11, 2020 21:52 ET
|
Generation Bio Co.
CAMBRIDGE, Mass., June 11, 2020 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq: GBIO), an innovative genetic medicines company creating a new class of gene therapy, today announced the pricing of...